Improving access to molecular tumour boards for complex genomic profiles: A healthcare policy from the Netherlands

被引:0
|
作者
van Doorn-Khosrovani, S. van Waalwijk [1 ]
Reparon, C. [2 ]
Koole, S. [3 ]
Huisman, A. [4 ]
Louis, C. [5 ]
Van Aart, M. [6 ]
Groenen, W. [7 ]
Grunberg, K. [8 ]
Schuuring, E. [9 ]
Smit, V. T. H. B. M. [10 ]
Monkhorst, K. [11 ]
Gelderblom, H. [12 ]
van der Flier, S. [13 ]
机构
[1] CZ Hlth Insurance Co, Dept Med, Tilburg, Netherlands
[2] Zilveren Kruis, Dept Med, Leiden, Netherlands
[3] ONVZ Hlth Insurance, Med Dept, Houte, Netherlands
[4] Zorgverzekeraars Nederland, Dept Medicines Policy, Zeist, Netherlands
[5] NFK Dutch Federat Canc Patient Organisat, Diagnost Advocacy, Utrecht, Netherlands
[6] CZ Hlth Insurance Co, Healthcare Transformat Strategy & Policy, Tilburg, Netherlands
[7] CZ Hlth Insurance Co, Specialized Care, Tilburg, Netherlands
[8] Radboud Univ Nijmegen Med Ctr, Dept Pathol, Nijmegen, Netherlands
[9] UMCG Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands
[10] LUMC Leiden Univ Med Ctr, Dept Pathol, Leiden, Netherlands
[11] NKI AVL Netherlands Canc Inst Antoni Leeuwenhoek, Dept Pathol, Amsterdam, Netherlands
[12] LUMC Leids Univ Med Centrum, Dept Med Oncol, Leiden, Netherlands
[13] VGZ Hlth Insurance, Dept Med, Arnhem, Netherlands
关键词
D O I
10.1016/j.annonc.2023.09.2677
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1723P
引用
收藏
页码:S938 / S938
页数:1
相关论文
共 50 条
  • [1] Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations
    Annelieke E. C. A. B. Willemsen
    Sarah Krausz
    Marjolijn J. L. Ligtenberg
    Katrien Grünberg
    Harry J. M. Groen
    Emile E. Voest
    Edwin P. J. G. Cuppen
    Hanneke W. M. van Laarhoven
    Carla M. L. van Herpen
    British Journal of Cancer, 2019, 121 : 34 - 36
  • [2] Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations
    Willemsen, Annelieke E. C. A. B.
    Krausz, Sarah
    Ligtenberg, Marjolijn J. L.
    Grunberg, Katrien
    Groen, Harry J. M.
    Voest, Emile E.
    Cuppen, Edwin P. J. G.
    van Laarhoven, Hanneke W. M.
    van Herpen, Carla M. L.
    BRITISH JOURNAL OF CANCER, 2019, 121 (01) : 34 - 36
  • [3] Genomic expertise in action: molecular tumour boards and decision-making in precision oncology
    Bourret, Pascale
    Cambrosio, Alberto
    SOCIOLOGY OF HEALTH & ILLNESS, 2019, 41 (08) : 1568 - 1584
  • [4] Genomic Sequencing Reveals Complex and Actionable Molecular Profiles across Hematologic Malignancies
    Galanina, Natalie
    Jamieson, Catriona
    Kurzrock, Razelle
    BLOOD, 2018, 132
  • [5] Evidence from systematic reviews on policy approaches to improving access to medicines
    Kuchena, Celestino
    Qutieshat, Abubaker
    HEALTHCARE IN LOW-RESOURCE SETTINGS, 2023, 11 (01)
  • [6] Role of the general practitioner in improving rural healthcare access: a case from Nepal
    Gauchan, Bikash
    Mehanni, Stephen
    Agrawal, Pawan
    Pathak, Mandeep
    Dhungana, Santosh
    HUMAN RESOURCES FOR HEALTH, 2018, 16
  • [7] Role of the general practitioner in improving rural healthcare access: a case from Nepal
    Bikash Gauchan
    Stephen Mehanni
    Pawan Agrawal
    Mandeep Pathak
    Santosh Dhungana
    Human Resources for Health, 16
  • [8] Integrating complex genomic datasets and tumour cell sensitivity profiles to address a 'simple' question: which patients should get this drug?
    Benes, Cyril
    Settleman, Jeff
    BMC MEDICINE, 2009, 7
  • [9] Integrating complex genomic datasets and tumour cell sensitivity profiles to address a 'simple' question: which patients should get this drug?
    Cyril Benes
    Jeff Settleman
    BMC Medicine, 7
  • [10] Improving Medicaid Access in Times of Health Policy Change: Solutions from Focus Groups
    Raymond-Flesch, Marissa
    Lucia, Laurel
    Jacobs, Ken
    Brindis, Claire D.
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2019, 30 (01) : 280 - 296